A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.

GLP-1s may help reduce alcohol intake among adults with overweight or obesity, according to data presented at the European ...

Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...

The decline was sharper after 2016, likely due to advancements in treatment options, greater uptake of precision medicine, ...

The decline was sharper after 2016, likely due to advancements in treatment options, greater uptake of precision medicine, and expanded access to care and screening in women ages 40-49, study ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...